How have IGX shares performed in 2024?

IntelGenx Technologies' stock was trading at C$0.58 at the beginning of 2024. Since then, IGX shares have increased by 0.0% and is now trading at C$0.58. View the best growth stocks for 2024 here .

What other stocks do shareholders of IntelGenx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include IntelGenx Technologies (IGXT) , Aurora Cannabis (ACB) , New Age Brands (NF) , Capstone Copper (CS) , Hanesbrands (HBI) , Tilray (TLRY) , ACADIA Pharmaceuticals (ACAD) , AusCann Group (AC8) , Cameco (CCJ) and Baylin Technologies (BYL) .

How do I buy shares of IntelGenx Technologies?

Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:IGX

IntelGenx Technologies (IGX) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free IGX Stock Alerts

C$0.58

+0.01 (+1.75%)

(As of 10/6/2021)

Compare

Today's Range: C$0.58
▼
C$0.60
50-Day Range: C$0.58
▼
C$0.58
52-Week Range: C$0.17
▼
C$0.85

Volume: 11,848 shs
Average Volume: 56,279 shs
Market Capitalization: C$87.32 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get IntelGenx Technologies alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About IntelGenx Technologies Stock (CVE:IGX)

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

IGX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IGX Stock News Headlines

April 8, 2024 | ca.finance.yahoo.com

Stocks in play: IntelGenx Corp.

April 5, 2024 | finanznachrichten.de

IntelGenx Technologies Corp.: IntelGenx Updates Status of Buprenorphine Buccal Film ANDA

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

February 20, 2024 | uk.finance.yahoo.com

IntelGenx Launches Preferred Share Regulation A Offering

January 11, 2024 | msn.com

NVIDIA partners with Amgen to build generative AI models for drug discovery

January 2, 2024 | finance.yahoo.com

CHANGES TO BOARD OF DIRECTORS OF GEEKCO

December 18, 2023 | finanznachrichten.de

IntelGenx Technologies Corp.: IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm

December 5, 2023 | finance.yahoo.com

IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

December 4, 2023 | finance.yahoo.com

IntelGenx Announces Changes to its Board of Directors

November 29, 2023 | finanznachrichten.de

IntelGenx Technologies Corp.: IntelGenx Announces Shareholder Approval of Financing Transactions

November 13, 2023 | theglobeandmail.com

Closing Bell: Intelgenx Technologies Corp up on Monday (IGX)

November 10, 2023 | finanznachrichten.de

IntelGenx Technologies Corp.: IntelGenx Reports Third Quarter 2023 Financial Results

November 7, 2023 | theglobeandmail.com

Closing Bell: Intelgenx Technologies Corp up on Tuesday (IGX)

November 2, 2023 | finance.yahoo.com

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow

October 21, 2023 | theglobeandmail.com

Closing Bell: Intelgenx Technologies Corp flat on Friday (IGX)

October 13, 2023 | theglobeandmail.com

Closing Bell: Intelgenx Technologies Corp down on Thursday (IGX)

October 7, 2023 | theglobeandmail.com

Closing Bell: Intelgenx Technologies Corp flat on Thursday (IGX)

September 19, 2023 | finance.yahoo.com

IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film

August 2, 2023 | msn.com

IntelGenx Technologies (IGXT) Price Target Increased by 8.03% to 0.79

July 25, 2023 | finanznachrichten.de

IntelGenx Technologies Corp.: IntelGenx Announces a Change to its Board of Directors

July 25, 2023 | finance.yahoo.com

IntelGenx Provides Update on Research Collaboration Evaluating Montelukast VersaFilm® for the Treatment of Parkinson’s Disease

May 31, 2023 | finance.yahoo.com

IntelGenx Unveils Short-Term Commercial Objectives

May 11, 2023 | marketwatch.com

8-K: IntelGenx Technologies Corp.

April 27, 2023 | finance.yahoo.com

IntelGenx Extends Period to Exercise Certain Warrants

April 27, 2023 | finance.yahoo.com

IntelGenx Announces Receipt of Complete Response Letter from the FDA for Xiromed-Partnered Buprenorphine Buccal Film

April 20, 2023 | theglobeandmail.com

Closing Bell: Intelgenx Technologies Corp up on Wednesday (IGX)

See More Headlines

Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:IGX
CUSIP: N/A
CIK: N/A
Web: www.intelgenx.com
Phone: 514-331-7440
Fax: N/A
Employees: 48
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 164.62
Current Ratio: 2.77
Quick Ratio: 2.69

Sales & Book Value

Annual Sales: C$1.75 million
Price / Sales: 49.95
Cash Flow: C$0.08 per share
Price / Cash Flow: 7.16
Book Value: C$0.05 per share
Price / Book: 12.89

Miscellaneous

Outstanding Shares: 150,546,000
Free Float: N/A
Market Cap: C$87.32 million
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Horst G. Zerbe (Age 74)
Chairman, CEO & Chairman of Scientific Advisory Board
Comp: $240.75k
Ms. Nadine Paiement (Age 44)
Vice-Chair of Scientific Advisory Board and VP of R&D - IntelGenx Corp
Comp: $140.13k
Dr. Dana Matzen (Age 43)
VP of Bus. & Corp. Devel. of IntelGenx Corp
Comp: $171.43k
Stephen Kilmer
Investor Relations Officer
Dr. Rodolphe Obeid Ph.D. (Age 41)
VP of Operations - IntelGenx Corp
Mr. Tommy Kenny J.D. (Age 34)
L.L.B., M.Sc., VP of Intellectual Property & Legal Affairs and Gen. Counsel of IntelGenx Corp
Ms. Ingrid Zerbe (Age 67)
Corp. Sec.

Key Competitors

View All Competitors

IGX Stock Analysis - Frequently Asked Questions

How have IGX shares performed in 2024?: IntelGenx Technologies' stock was trading at C$0.58 at the beginning of 2024. Since then, IGX shares have increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2024 here.
What other stocks do shareholders of IntelGenx Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), Aurora Cannabis (ACB), New Age Brands (NF), Capstone Copper (CS), Hanesbrands (HBI), Tilray (TLRY), ACADIA Pharmaceuticals (ACAD), AusCann Group (AC8), Cameco (CCJ) and Baylin Technologies (BYL).
How do I buy shares of IntelGenx Technologies?: Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:IGX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial